Methotrexate

CAS No. 59-05-2

Methotrexate( Amethopterin | CL 14,377 | EMT 25299 | MTX | NSC 740 | R 9985 )

Catalog No. M15186 CAS No. 59-05-2

Methotrexate, a folate antagonist, is a potent anti-inflammatory agent when used weekly in low concentrations.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 34 In Stock
100MG 49 In Stock
200MG 73 In Stock
500MG 128 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Methotrexate
  • Note
    Research use only, not for human use.
  • Brief Description
    Methotrexate, a folate antagonist, is a potent anti-inflammatory agent when used weekly in low concentrations.
  • Description
    Methotrexate, a folate antagonist, is a potent anti-inflammatory agent when used weekly in low concentrations, the anti-phlogistic action of which is due to increased adenosine release at inflamed sites. Studies have demonstrated that methotrexate polyglutamates are active inhibitors of several enzymatic reactions, including dihydrofolate reductase.(In Vivo):Methotrexate (Amethopterin) reduces thymus and spleen indices of mice. Methotrexate markedly decreases white blood cells, thymic and splenic lymphocytes at dose ≥5 mg/kg. However, there is a significant difference between the treatment plus control group and the model group (p<0.01). The combination of grape seed proanthocyanidins and Siberian ginseng eleutherosides obviously diminishes the effects of Methotrexate exposure on indices of thymus and spleens in mice.Methotrexate (MTX) (2 mg/kg; i.p.; once in a week for 5 weeks) is effective in Freund's complete adjuvant-induced arthritis. The combination of Methotrexate (1 mg/kg; i.p.; once in a week for 5 weeks) and Curcumin (30 mg/kg and 100 mg/kg, thrice a week for 5 weeks; i.p.) shows a significant anti-arthritic action and protection from hematological toxicity.
  • In Vitro
    ——
  • In Vivo
    Methotrexate (Amethopterin) reduces thymus and spleen indices of mice. Methotrexate markedly decreases white blood cells, thymic and splenic lymphocytes at dose ≥5 mg/kg. However, there is a significant difference between the treatment plus control group and the model group (p<0.01). The combination of grape seed proanthocyanidins and Siberian ginseng eleutherosides obviously diminishes the effects of Methotrexate exposure on indices of thymus and spleens in mice.Methotrexate (MTX) (2 mg/kg; i.p.; once in a week for 5 weeks) is effective in Freund's complete adjuvant-induced arthritis. The combination of Methotrexate (1 mg/kg; i.p.; once in a week for 5 weeks) and Curcumin (30 mg/kg and 100 mg/kg, thrice a week for 5 weeks; i.p.) shows a significant anti-arthritic action and protection from hematological toxicity.
  • Synonyms
    Amethopterin | CL 14,377 | EMT 25299 | MTX | NSC 740 | R 9985
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Dehydrogenase
  • Recptor
    hDHFR
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    59-05-2
  • Formula Weight
    454.44
  • Molecular Formula
    C20H22N8O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 90 mg/mL warmed (198.04 mM)
  • SMILES
    CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Al-Rashood ST, et al. Bioorg Med Chem. 2006 Dec 15;14(24):8608-2
molnova catalog
related products
  • ALDH1A3-IN-2

    ALDH1A3-IN-2 is a potent ALDH1A3 inhibitor with an IC50 of 0.30 μM.ALDH1A3-IN-2 has potential for cancer disease research.

  • DSM265

    DSM265 (PfSPZ) is a dihydroorotic acid dehydrogenase inhibitor with antimalarial activity (IC50: 8.9 nM).DSM265 inhibits the growth of Pf3D7 parasites and can be used for the treatment and prophylaxis of malaria infections.

  • CM 10

    CM 10 is an aldehyde dehydrogenase 1A family(ALDH1A) inhibitor.